These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17498699)

  • 1. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
    Butsch PO; Cudkowicz ME
    Exp Neurol; 2007 Jul; 206(1):11-5. PubMed ID: 17498699
    [No Abstract]   [Full Text] [Related]  

  • 2. The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons.
    Chung JY; Kim HJ; Kim M
    BMC Neurosci; 2015 Feb; 16(1):1. PubMed ID: 25655275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edaravone in ALS.
    Takahashi R
    Exp Neurol; 2009 Jun; 217(2):235-6. PubMed ID: 19285071
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
    Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
    Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
    Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model.
    Grunfeld JF; Barhum Y; Blondheim N; Rabey JM; Melamed E; Offen D
    Exp Neurol; 2007 Mar; 204(1):260-3. PubMed ID: 17174305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease: a chemical perspective.
    Wood LK; Langford SJ
    J Med Chem; 2014 Aug; 57(15):6316-31. PubMed ID: 24694032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD1) gene.
    Mitsumoto H
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Mar; 1(2):69-70. PubMed ID: 11467052
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurobiology. Stay the executioner's hand.
    Gurney ME; Tomasselli AG; Heinrikson RL
    Science; 2000 Apr; 288(5464):283-4. PubMed ID: 10777410
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
    J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk5 sinks into ALS.
    Patzke H; Tsai LH
    Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ALS activity of alsin, the product of the ALS2 gene, and activity-dependent neurotrophic factor.
    Matsuoka M; Nishimoto I
    Neurodegener Dis; 2005; 2(3-4):135-8. PubMed ID: 16909018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
    Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF
    Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
    Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Abe K
    Neurol Res; 2003 Mar; 25(2):195-200. PubMed ID: 12635522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Carri MT; Youdim MB
    FASEB J; 2009 Nov; 23(11):3766-79. PubMed ID: 19638399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin does not preserve motor neurons in a mouse model of familial ALS.
    Grignaschi G; Zennaro E; Tortarolo M; Calvaresi N; Bendotti C
    Amyotroph Lateral Scler; 2007 Feb; 8(1):31-5. PubMed ID: 17364433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.